Rationale and Design of REGINA, a Phase II Trial of Neoadjuvant Regorafenib, Nivolumab, and Short-Course Radiotherapy in Stage II and III Rectal Cancer
Acta oncologica (Stockholm, Sweden)（2021）
Key words
Neoadjuvant Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined